• 37
Reading Time: 6 minutes

Among the many factors that determine whether a diabetic foot ulcer heals or progresses toward infection and amputation, one mechanical principle stands above the rest: repetitive pressure must be removed from the wound. Most diabetic foot ulcers form on the weight-bearing surface of an insensate foot, where peripheral neuropathy has erased the protective pain that would normally make a person limp, shift weight, or stop walking. Without that warning system, every step delivers concentrated force to the same patch of tissue, breaking down the wound bed faster than it can rebuild. Redistributing or eliminating that load — a practice called offloading — is widely regarded as the cornerstone of diabetic foot ulcer care.

Why pressure relief drives healing

The biological logic is straightforward. Healing requires that new cells migrate across and populate the wound bed undisturbed. Repeated mechanical trauma disrupts this process, sustains inflammation, and thickens surrounding callus, which itself raises local pressure further. International guidance reflects how central this concept has become. The International Working Group on the Diabetic Foot (IWGDF), which has issued evidence-based diabetic foot guidelines since 1999 and updated them most recently in 2023, identifies offloading as one of the core pillars of ulcer management alongside vascular assessment, infection control, and wound care (Schaper et al., 2020; Bus et al., 2023).

Total contact casting: the reference standard

When clinicians compare offloading methods, the total contact cast (TCC) consistently emerges as the most effective. A TCC is a well-molded, minimally padded cast that distributes pressure across the entire plantar surface and lower leg, sharply reducing force at the ulcer site. In a systematic review of offloading devices, de Oliveira and Moore (2015) found that total contact casting produced superior healing rates, faster healing times, and greater reductions in ulcer size than competing devices.

A key reason for this advantage is that a TCC cannot be removed by the patient. Because it stays on continuously, it enforces offloading around the clock rather than relying on the wearer’s discipline. A secondary analysis by Wendland and colleagues (2023) illustrated this vividly: among patients with neuropathic plantar ulcers, 93% of those treated with a total contact cast healed, compared with 65% of those using a removable cast walker, and average healing time was shorter (roughly 77 days versus 138 days). Patients in removable devices took more daily steps, suggesting that the ability to take a device off — and the extra walking it permits — undermines healing.

Practical trade-offs and newer cast designs

Despite strong evidence, total contact casts remain underused worldwide. Application is technically demanding and time-consuming, and the cast can affect gait, sleep, bathing, and transportation. Researchers have therefore explored variations that preserve offloading while easing these burdens. Liden (2017) reported a streamlined TCC system that could be applied in about seven minutes and allowed immediate walking; in a small case series, 18 of 20 wounds (90%) healed in a mean of roughly 22 days. Vierhout and colleagues (2022) compared a non-removable total contact softcast with a conventional TCC and found comparable healing ratios, with a trend toward shorter healing time for the softcast. Other groups have described windowed casts that retain irremovability while allowing the wound to be inspected (Hochlenert and Fischer, 2020).

When casting is not appropriate

Total contact casting is not suitable for every patient. Because the cast encases an insensate limb and applies pressure broadly, it is traditionally contraindicated in the presence of significant peripheral arterial disease (PAD), active infection, or deep, heavily exudating wounds. Tickner and colleagues (2018), in a case series and systematic review, examined where the vascular threshold lies and suggested that casting may remain viable in mild-to-moderate PAD when perfusion exceeds certain limits — for example, an ankle pressure of at least 80 mm Hg or an ankle-brachial index of at least 0.55 — while emphasizing careful vascular evaluation, close follow-up, and patient selection. In patients for whom irremovable casting is unsafe or impractical, removable cast walkers, healing sandals, and accommodative footwear remain valuable alternatives, particularly when their adherence can be reinforced.

Key takeaways

Offloading is the mechanical foundation of diabetic foot ulcer healing. The best available evidence favors continuous, non-removable pressure relief, with total contact casting serving as the reference standard against which other methods are measured. Its effectiveness appears to rest as much on enforced consistency as on its biomechanics: devices that patients can remove are associated with more walking and poorer outcomes. At the same time, casting carries real contraindications — notably significant arterial disease and infection — and demands skilled application and vigilant monitoring. The practical lesson from the literature is that the method matters less than achieving sustained, around-the-clock reduction of pressure on the wound, matched appropriately to each patient’s vascular status, wound characteristics, and circumstances.

References

Bus, S.A., Monteiro-Soares, M., Game, F., et al. (2023). Standards for the development and methodology of the 2023 IWGDF guidelines. Diabetes/Metabolism Research and Reviews, 40(3), e3656.

de Oliveira, A.L.M., & Moore, Z. (2015). Treatment of the diabetic foot by offloading: a systematic review. Journal of Wound Care, 24(12), 560–570.

Hochlenert, D., & Fischer, C. (2020). Ventral windowed total contact casts safely offload diabetic feet and allow access to the foot. Journal of Diabetes Science and Technology, 16(1), 137–143.

Liden, B. (2017). Total contact cast system to heal diabetic foot ulcers. Surgical Technology International, 30, 71–76.

Schaper, N.C., van Netten, J.J., Apelqvist, J., et al. (2020). Practical guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update). Diabetes/Metabolism Research and Reviews, 36(S1), e3266.

Tickner, A., Klinghard, C., Arnold, J.F., & Marmolejo, V. (2018). Total contact cast use in patients with peripheral arterial disease: a case series and systematic review. Wounds, 30(2), 49–56.

Vierhout, B.P., Visser, R., Hutting, K.H., et al. (2022). Comparing a non-removable total contact cast with a non-removable softcast in diabetic foot ulcers. Diabetes Research and Clinical Practice, 191, 110036.

Wendland, D.M., Kline, P.W., Bohnert, K.L., Biven, T.M., & Sinacore, D.R. (2023). Offloading of diabetic neuropathic plantar ulcers: secondary analysis of step activity and ulcer healing. Advances in Skin & Wound Care, 36(4), 194–200.

Comments

comments

Author

PV Mayer

Dr. Perry Mayer is the Medical Director of The Mayer Institute (TMI), a center of excellence in the treatment of the diabetic foot. He received his undergraduate degree from Queen’s University, Kingston and medical degree from the Royal College of Surgeons in Ireland.